What is Sentiar?
Sentiar is a pioneering digital health and medical technology enterprise dedicated to revolutionizing interventional procedures. The company specializes in augmented reality and real-time holographic visualization, providing clinicians with an immersive three-dimensional environment to monitor patient anatomy and catheter positioning during minimally invasive surgeries. By integrating these sophisticated software platforms into the clinical workflow, Sentiar enhances procedural precision, improves decision-making, and optimizes overall healthcare efficiency. The firm sits at the intersection of high-growth MedTech and digital health, addressing the critical need for safer, more intuitive guidance in complex medical environments.
How much funding has Sentiar raised?
Sentiar has raised a total of $16.3M across 5 funding rounds:
Angel/Seed
$1.1M
Debt
$144K
Series A
$5.1M
Series B
$8.5M
Debt
$1.5M
Angel/Seed (2017): $1.1M, investors not publicly disclosed
Debt (2021): $144K led by PPP
Series A (2021): $5.1M supported by Cultivation Capital, QRM Capital, Neue Fund, VCapital, BioGenerator Company, Keiretsu Forum, and TechWald Holding S.p.A
Series B (2023): $8.5M featuring TechWald Holding SpA, VCapital, and MedVenture Partners
Debt (2026): $1.5M, investors not publicly disclosed
Key Investors in Sentiar
Cultivation Capital
A venture capital firm that invests in young companies with transformative ideas across various industries, including life sciences and software, providing capital resources to help startups navigate hyper growth.
VCapital
A Chicago-based venture capital firm focused on early-stage companies, with a strategic investment mandate spanning medical devices, biotechnology, and telecommunications.
Keiretsu Forum
A global membership organization comprised of angel investors, venture capitalists, and serial entrepreneurs dedicated to supporting innovative early-stage ventures.
What's next for Sentiar?
With this major strategic investment, Sentiar is poised to transition into a new phase of commercial expansion and technological refinement. The company is expected to focus on deepening its integration within hospital systems and broadening the clinical applications of its holographic software. As the firm moves beyond its initial development and scaling phases, the focus will likely shift toward securing broader regulatory approvals and establishing strategic partnerships with global medical device manufacturers. This capital provides the necessary runway to solidify its market position as a leader in the augmented reality surgical space, ultimately aiming to set a new standard for procedural visualization and patient outcomes in the global healthcare market.
See full Sentiar company page
